Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Characterization of the relationship between neutron production and thermal load on a target material in an accelerator-based boron neutron capture therapy system employing a solid-state Li target.

Nakamura S, Igaki H, Ito M, Okamoto H, Nishioka S, Iijima K, Nakayama H, Takemori M, Imamichi S, Kashihara T, Takahashi K, Inaba K, Okuma K, Murakami N, Abe Y, Nakayama Y, Masutani M, Nishio T, Itami J.

PLoS One. 2019 Nov 22;14(11):e0225587. doi: 10.1371/journal.pone.0225587. eCollection 2019.

2.

Thioredoxin-1 maintains mitochondrial function via mTOR signaling in the heart.

Oka SI, Chin A, Park JY, Ikeda S, Mizushima W, Ralda G, Zhai P, Tong M, Byun J, Tang F, Einaga Y, Huang CY, Kashihara T, Zhao M, Nah J, Tian B, Hirabayashi Y, Yodoi J, Sadoshima J.

Cardiovasc Res. 2019 Oct 4. pii: cvz251. doi: 10.1093/cvr/cvz251. [Epub ahead of print]

PMID:
31584633
3.

YAP-dependent metabolic remodeling in local lymph node boosts the function of cancer cells.

Kashihara T, Zablocki D, Sadoshima J.

Biotarget. 2019 Aug;3. pii: 14. doi: 10.21037/biotarget.2019.08.01. Epub 2019 Aug 23. No abstract available.

4.

Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy.

Murakami N, Mori T, Nakamura S, Yoshimoto S, Honma Y, Ueno T, Kobayashi K, Kashihara T, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Itami J.

J Radiat Res. 2019 Nov 22;60(6):803-811. doi: 10.1093/jrr/rrz053.

5.

Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients.

Tsuchida K, Murakami N, Kato T, Okuma K, Okamoto H, Kashihara T, Takahashi K, Inaba K, Igaki H, Nakayama Y, Nakano T, Itami J.

J Radiat Res. 2019 Oct 23;60(5):650-657. doi: 10.1093/jrr/rrz041.

6.

Artificial ascites for organs at risk sparing in intrapelvic brachytherapy: a case report of recurrent uterine cervical carcinoma adjacent to the bowel.

Murakami N, Shima S, Okuma K, Iijima K, Tselis N, Uematsu M, Takagawa Y, Kashihara T, Masui K, Yoshida K, Takahashi K, Inaba K, Igaki H, Nakayama Y, Itami J.

BJR Case Rep. 2018 Aug 11;5(1):20180067. doi: 10.1259/bjrcr.20180067. eCollection 2019 Feb.

7.

Dose escalation of external beam radiotherapy for high-risk prostate cancer-Impact of multiple high-risk factor.

Umezawa R, Inaba K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Murakami N, Ito Y, Igaki H, Jingu K, Itami J.

Asian J Urol. 2019 Apr;6(2):192-199. doi: 10.1016/j.ajur.2017.07.002. Epub 2017 Oct 19.

8.

Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience.

Kashihara T, Murakami N, Tselis N, Kobayashi K, Tsuchida K, Shima S, Masui K, Yoshida K, Takahashi K, Inaba K, Umezawa R, Igaki H, Ito Y, Kato T, Uno T, Itami J.

J Radiat Res. 2019 Jul 1;60(4):501-508. doi: 10.1093/jrr/rrz016.

9.

Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction.

Murakami N, Shima S, Kashihara T, Tselis N, Kato T, Takagawa Y, Masui K, Yoshida K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Itami J.

J Contemp Brachytherapy. 2019 Feb;11(1):1-7. doi: 10.5114/jcb.2019.82612. Epub 2019 Jan 29.

10.

A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience.

Murakami N, Kobayashi K, Shima S, Tsuchida K, Kashihara T, Tselis N, Umezawa R, Takahashi K, Inaba K, Ito Y, Igaki H, Nakayama Y, Masui K, Yoshida K, Kato T, Itami J.

BMC Cancer. 2019 Mar 12;19(1):221. doi: 10.1186/s12885-019-5430-x.

11.

Hemorrhage from Ascending Colon and Gluteal Muscle Associated with Sorafenib and Radiation Therapy: Radiation Dose Distribution Corresponded with Colonoscopy Findings and Computed Tomography Images.

Kashihara T, Murakami N, Iizumi S, Sakamoto Y, Nakamura S, Iijima K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Okusaka T, Uno T, Itami J.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):214-219. doi: 10.1016/j.prro.2019.02.012. Epub 2019 Feb 27. No abstract available.

PMID:
30825665
12.

Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice.

Yamada Y, Harada M, Hashimoto K, Guo R, Nakajima T, Kashihara T, Yamada M, Aoyama T, Kamijo Y.

Glycoconj J. 2019 Feb;36(1):1-11. doi: 10.1007/s10719-018-9850-7. Epub 2018 Dec 10.

PMID:
30536036
13.

Effects of hypertension and antihypertensive treatments on sulfatide levels in serum and its metabolism.

Guo R, Hu X, Yamada Y, Harada M, Nakajima T, Kashihara T, Yamada M, Aoyama T, Kamijo Y.

Hypertens Res. 2019 May;42(5):598-609. doi: 10.1038/s41440-018-0160-z. Epub 2018 Dec 10.

PMID:
30531843
14.

Prostanoid EP4 Receptor-Mediated Augmentation of I h Currents in Aβ Dorsal Root Ganglion Neurons Underlies Neuropathic Pain.

Zhang H, Kashihara T, Nakada T, Tanaka S, Ishida K, Fuseya S, Kawagishi H, Kiyosawa K, Kawamata M, Yamada M.

J Pharmacol Exp Ther. 2019 Jan;368(1):50-58. doi: 10.1124/jpet.118.252767. Epub 2018 Nov 8.

PMID:
30409832
15.

Physical interaction of junctophilin and the CaV1.1 C terminus is crucial for skeletal muscle contraction.

Nakada T, Kashihara T, Komatsu M, Kojima K, Takeshita T, Yamada M.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4507-4512. doi: 10.1073/pnas.1716649115. Epub 2018 Apr 9.

16.

Long-term Results of External Beam Radiotherapy for Prostate Cancer with Prostate-specific Antigen of More Than 50 ng/ml and Without Evidence of Lymph Node or Distant Metastasis.

Umezawa R, Inaba K, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Murakami N, Ito Y, Igaki H, Jingu K, Itami J.

Anticancer Res. 2018 Apr;38(4):2303-2309.

PMID:
29599353
17.

Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.

Kashihara T, Nakamura S, Wakita A, Okamoto H, Inaba K, Umezawa R, Shima S, Tsuchida K, Kobayashi K, Takahashi K, Murakami N, Ito Y, Igaki H, Fujimoto H, Uno T, Itami J.

Cancer Med. 2018 May;7(5):1723-1730. doi: 10.1002/cam4.1408. Epub 2018 Mar 23.

18.

PDGF-induced migration of synthetic vascular smooth muscle cells through c-Src-activated L-type Ca2+ channels with full-length CaV1.2 C-terminus.

Guo X, Kashihara T, Nakada T, Aoyama T, Yamada M.

Pflugers Arch. 2018 Jun;470(6):909-921. doi: 10.1007/s00424-018-2114-3. Epub 2018 Feb 13.

PMID:
29441404
19.

Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.

Umezawa R, Murakami N, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Inaba K, Ito Y, Igaki H, Masui K, Yoshida K, Jingu K, Tselis N, Itami J.

Brachytherapy. 2018 Mar - Apr;17(2):368-376. doi: 10.1016/j.brachy.2017.11.011. Epub 2017 Dec 21.

PMID:
29275869
20.

Crucial role of 4-deoxy-L-erythro-5-hexoseulose uronate reductase for alginate utilization revealed by adaptive evolution in engineered Saccharomyces cerevisiae.

Matsuoka F, Hirayama M, Kashihara T, Tanaka H, Hashimoto W, Murata K, Kawai S.

Sci Rep. 2017 Jun 23;7(1):4206. doi: 10.1038/s41598-017-04481-3.

21.

Improvement of lipid production by the oleaginous yeast Rhodosporidium toruloides through UV mutagenesis.

Yamada R, Kashihara T, Ogino H.

World J Microbiol Biotechnol. 2017 May;33(5):99. doi: 10.1007/s11274-017-2269-7. Epub 2017 Apr 20.

PMID:
28429279
22.

Angiotensin II activates CaV 1.2 Ca2+ channels through β-arrestin2 and casein kinase 2 in mouse immature cardiomyocytes.

Kashihara T, Nakada T, Kojima K, Takeshita T, Yamada M.

J Physiol. 2017 Jul 1;595(13):4207-4225. doi: 10.1113/JP273883. Epub 2017 Apr 20.

23.

The role of interstitial brachytherapy in the management of primary radiation therapy for uterine cervical cancer.

Murakami N, Kobayashi K, Kato T, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Harada K, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

J Contemp Brachytherapy. 2016 Oct;8(5):391-398. Epub 2016 Oct 10.

24.

Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy.

Inaba K, Okamoto H, Wakita A, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Murakami N, Ito Y, Igaki H, Uno T, Itami J.

Radiother Oncol. 2016 Jul;120(1):145-9. doi: 10.1016/j.radonc.2016.04.022. Epub 2016 Jun 29.

PMID:
27372224
25.

Erratum: A total EQD2 greater than 85 Gy for trachea and main bronchus D2cc being associated with severe late complications after definitive endobronchial brachytherapy.

Murakami N, Kobayashi K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Harada K, Yamada M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

J Contemp Brachytherapy. 2016 Apr;8(2):164. doi: 10.5114/jcb.2016.59694. Epub 2016 Apr 29.

26.

Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy.

Murakami N, Kato T, Miyamoto Y, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

Anticancer Res. 2016 May;36(5):2413-21.

PMID:
27127151
27.

Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.

Murakami N, Matsumoto F, Yoshimoto S, Ito Y, Mori T, Ueno T, Tuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Inaba K, Igaki H, Itami J.

BMC Cancer. 2016 Mar 7;16:192. doi: 10.1186/s12885-016-2229-x.

28.

A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma.

Watanabe T, Tobinai K, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Kashihara T, Iida S.

Br J Haematol. 2016 Mar;172(5):745-56. doi: 10.1111/bjh.13900. Epub 2016 Jan 5.

29.

Early-onset dropped head syndrome after radiotherapy for head and neck cancer: dose constraints for neck extensor muscles.

Inaba K, Nakamura S, Okamoto H, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Murakami N, Ito Y, Igaki H, Uno T, Itami J.

J Radiat Res. 2016 Mar;57(2):169-73. doi: 10.1093/jrr/rrv055. Epub 2015 Dec 18.

30.

A total EQD2 greater than 85 Gy for trachea and main bronchus D2cc being associated with severe late complications after definitive endobronchial brachytherapy.

Murakami N, Kobayashi K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Harada K, Yamada M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

J Contemp Brachytherapy. 2015 Oct;7(5):363-8. doi: 10.5114/jcb.2015.54968. Epub 2015 Oct 13. Erratum in: J Contemp Brachytherapy. 2016 Apr;8(2):164.

31.

Transplantation of adipose tissue-derived stem cells improves cardiac contractile function and electrical stability in a rat myocardial infarction model.

Gautam M, Fujita D, Kimura K, Ichikawa H, Izawa A, Hirose M, Kashihara T, Yamada M, Takahashi M, Ikeda U, Shiba Y.

J Mol Cell Cardiol. 2015 Apr;81:139-49. doi: 10.1016/j.yjmcc.2015.02.012. Epub 2015 Feb 24.

PMID:
25724725
32.

Cardiac overexpression of constitutively active Galpha q causes angiotensin II type1 receptor activation, leading to progressive heart failure and ventricular arrhythmias in transgenic mice.

Matsushita N, Kashihara T, Shimojo H, Suzuki S, Nakada T, Takeishi Y, Mende U, Taira E, Yamada M, Sanbe A, Hirose M.

PLoS One. 2014 Aug 29;9(8):e106354. doi: 10.1371/journal.pone.0106354. eCollection 2014.

33.

Phlorizin prevents electrically-induced ventricular tachyarrhythmia during ischemia in langendorff-perfused guinea-pig hearts.

Hirose M, Shibazaki T, Nakada T, Kashihara T, Yano S, Okamoto Y, Isaji M, Matsushita N, Taira E, Yamada M.

Biol Pharm Bull. 2014;37(7):1168-76.

34.

β(2)-Adrenergic and M(2)-muscarinic receptors decrease basal t-tubular L-type Ca2+ channel activity and suppress ventricular contractility in heart failure.

Kashihara T, Hirose M, Shimojo H, Nakada T, Gomi S, Hongo M, Yamada M.

Eur J Pharmacol. 2014 Feb 5;724:122-31. doi: 10.1016/j.ejphar.2013.12.037. Epub 2013 Dec 31.

PMID:
24389135
35.

Novel regulation of cardiac metabolism and homeostasis by the adrenomedullin-receptor activity-modifying protein 2 system.

Yoshizawa T, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Iesato Y, Koyama T, Uetake R, Yang L, Yamauchi A, Tanaka M, Toriyama Y, Igarashi K, Nakada T, Kashihara T, Yamada M, Kawakami H, Nakanishi H, Taguchi R, Nakanishi T, Akazawa H, Shindo T.

Hypertension. 2013 Feb;61(2):341-51. doi: 10.1161/HYPERTENSIONAHA.111.00647. Epub 2013 Jan 7.

PMID:
23297372
36.

Nicorandil prevents Gαq-induced progressive heart failure and ventricular arrhythmias in transgenic mice.

Hirose M, Takeishi Y, Nakada T, Shimojo H, Kashihara T, Nishio A, Suzuki S, Mende U, Matsumoto K, Matsushita N, Taira E, Sato F, Yamada M.

PLoS One. 2012;7(12):e52667. doi: 10.1371/journal.pone.0052667. Epub 2012 Dec 20.

37.

The proximal C-terminus of α(1C) subunits is necessary for junctional membrane targeting of cardiac L-type calcium channels.

Nakada T, Flucher BE, Kashihara T, Sheng X, Shibazaki T, Horiuchi-Hirose M, Gomi S, Hirose M, Yamada M.

Biochem J. 2012 Dec 1;448(2):221-31. doi: 10.1042/BJ20120773.

PMID:
22928916
38.

Two mechanistically distinct effects of dihydropyridine nifedipine on CaV1.2 L-type Ca²⁺ channels revealed by Timothy syndrome mutation.

Sheng X, Nakada T, Kobayashi M, Kashihara T, Shibazaki T, Horiuchi-Hirose M, Gomi S, Hirose M, Aoyama T, Yamada M.

Eur J Pharmacol. 2012 Jun 15;685(1-3):15-23. doi: 10.1016/j.ejphar.2012.04.029. Epub 2012 Apr 23.

PMID:
22554770
39.

Chronic receptor-mediated activation of Gi/o proteins alters basal t-tubular and sarcolemmal L-type Ca²⁺ channel activity through phosphatases in heart failure.

Kashihara T, Nakada T, Shimojo H, Horiuchi-Hirose M, Gomi S, Shibazaki T, Sheng X, Hirose M, Hongo M, Yamada M.

Am J Physiol Heart Circ Physiol. 2012 Apr 15;302(8):H1645-54. doi: 10.1152/ajpheart.00589.2011. Epub 2012 Feb 3.

40.

Diacylglycerol kinase ζ inhibits ventricular tachyarrhythmias in a mouse model of heart failure.

Hirose M, Takeishi Y, Niizeki T, Nakada T, Shimojo H, Kashihara T, Horiuchi-Hirose M, Kubota I, Mende U, Yamada M.

Circ J. 2011;75(10):2333-42. Epub 2011 Jul 20.

41.

Decrease in the density of t-tubular L-type Ca2+ channel currents in failing ventricular myocytes.

Horiuchi-Hirose M, Kashihara T, Nakada T, Kurebayashi N, Shimojo H, Shibazaki T, Sheng X, Yano S, Hirose M, Hongo M, Sakurai T, Moriizumi T, Ueda H, Yamada M.

Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H978-88. doi: 10.1152/ajpheart.00508.2010. Epub 2010 Dec 30.

42.

Lupin pyranoisoflavones inhibiting hyphal development in arbuscular mycorrhizal fungi.

Akiyama K, Tanigawa F, Kashihara T, Hayashi H.

Phytochemistry. 2010 Nov;71(16):1865-71. doi: 10.1016/j.phytochem.2010.08.010. Epub 2010 Aug 31.

PMID:
20813384
43.

[Investigation of simplified international diagnostic criteria for autoimmune hepatitis].

Kaneko A, Kubo M, Yamada R, Tanimura T, Yamaguchi D, Yamamoto M, Tatsumi N, Nakama A, Mita E, Kato M, Hijioka T, Oshita M, Ito T, Imanaka K, Katayama K, Sato M, Yoshihara H, Kiriyama K, Imai Y, Kashihara T, Fukui H, Suzuki K, Miyoshi S, Yamada A, Yakushijin T, Mochizuki K, Hiramatsu N, Takehara T, Hayashi N.

Nihon Shokakibyo Gakkai Zasshi. 2010 May;107(5):732-42. Japanese.

PMID:
20460847
44.

[A case of type 4 gastric cancer with peritoneal dissemination complicating venous thromboembolism treated effectively by combination of S-1 and warfarin].

Murayama Y, Sano I, Doi Y, Iwasaki R, Chatani T, Horiki M, Kitada M, Okuno M, Kondo S, Fukuda H, Kashihara T.

Gan To Kagaku Ryoho. 2010 Feb;37(2):311-4. Japanese.

PMID:
20154492
45.

Werner syndrome as a possible cause of non-alcoholic steatohepatitis.

Hashizume H, Sato K, Takagi H, Kanda D, Kashihara T, Kiso S, Mori M.

J Clin Pathol. 2009 Nov;62(11):1043-5. doi: 10.1136/jcp.2009.070680. Epub 2009 Aug 30.

PMID:
19720629
46.

Differential involvement of alpha1-adrenoceptors in vasoconstrictor responses to cooling in mouse plantar arteries in vitro and in vivo.

Kashihara T, Goto K, Sahara Y, Nakayama K, Ishikawa T.

J Smooth Muscle Res. 2009 Jun;45(2-3):87-95.

47.

Role of Na+/Ca2+ exchanger-mediated Ca2+ entry in pressure-induced myogenic constriction in rat posterior cerebral arteries.

Kashihara T, Nakayama K, Matsuda T, Baba A, Ishikawa T.

J Pharmacol Sci. 2009 Jun;110(2):218-22. Epub 2009 Jun 5.

48.

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance.

Kurashige N, Ohkawa K, Hiramatsu N, Yakushijin T, Mochizuki K, Oze T, Kiso S, Kanto T, Takehara T, Kasahara A, Doi Y, Yamada A, Fukuda K, Oshita M, Mita E, Fukui H, Nagase T, Yoshihara H, Imai Y, Kato M, Kashihara T, Hayashi N.

J Gastroenterol. 2009;44(8):864-70. doi: 10.1007/s00535-009-0076-0. Epub 2009 May 28.

PMID:
19475333
49.

Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B.

Kurashige N, Hiramatsu N, Ohkawa K, Yakushijin T, Kiso S, Kanto T, Takehara T, Kasahara A, Doi Y, Yamada A, Oshita M, Mita E, Hagiwara H, Nagase T, Yoshihara H, Hayashi E, Imai Y, Kato M, Kashihara T, Hayashi N.

J Gastroenterol. 2009;44(6):601-7. doi: 10.1007/s00535-009-0038-6. Epub 2009 Apr 22.

PMID:
19387534
50.

Distinct roles of protein kinase C isoforms in myogenic constriction of rat posterior cerebral arteries.

Kashihara T, Nakayama K, Ishikawa T.

J Pharmacol Sci. 2008 Dec;108(4):446-54. Epub 2008 Dec 5.

Supplemental Content

Loading ...
Support Center